18F-P3BZA could become the new gold standard
Treatment for neuroendocrine tumors
CE Mark expiring this month
System moves on eight different axes with single controller
Creating 3D images of entire human body in 15-30 seconds
Free-floating, flat tabletop; affordable option for ambulatory settings
Used the da Vinci Xi Surgical System
Bringing the RAPID platform to the portable CereTom CT
Reducing turnaround time from 11 days down to three
Minimize axillary surgeries in patients who may not benefit from them
Vendor-neutral, operates on iPad Pro
Can measure the absorbed dose from MRT for individual patients
No injections, dyes, radiation, direct patient contact or interruptions in procedures
How emerging technologies are good medicine for an ailing health system
One more month for equipment stakeholders to make their voices heard
Supports global clinical trials across all therapeutic areas
Ensures quality control is present in laying out surgical plans
Can help select which stroke patients require clot removal procedures
Can hear the minuscule noises of bacteria and living cells
Breaking down barriers for better clinical outcomes
Offer CT, MR, mammography, ultrasound and OPG services
May lead to better treatment for neurological disorders
Jobs impacted will include 569 positions and 96 contractors
Involves monthslong shutdown of NTP Radioisotopes medical isotope plant
Integrated into GE PACS without changes to workflow
Complex figures and codes, and little insight into out-of-pocket costs
Partnered with Apollo Hospitals and Genworks
Resolution after whistleblower fraud lawsuit three years ago
Roughly $500 million in development planned or underway
Claims to not have had access to X-ray before procedure
Utilizing FDA-cleared QTscan technology
CT and MR images will be used to determine risk
Seeking to better align its businesses with consumer needs
Part of plans to ramp up international presence
Fundamental changes are reinventing the consumer's healthcare experience
Used in PET diagnostic exams for suspected neuroendocrine tumors
Examined disparities in screening mammography utilization at city level
A complex problem and a call for better dose optimization
Measures brain atrophy, detects white matter hyperintensities
Marks entrance into Nevada market